Allen Family Clinic Pllc. in Allen, KY - Clinic/Center

Allen Family Clinic Pllc. is a primary clinic (Clinic/center - Primary Care) in Allen, Kentucky. The current practice location for Allen Family Clinic Pllc. is 27 Ballpark St, Allen, Kentucky. For appointments, you can reach them via phone at (606) 874-1444. The mailing address for Allen Family Clinic Pllc. is Po Box 262, Allen, Kentucky and phone number is (606) 874-1444.

Allen Family Clinic Pllc. is licensed to practice in Kentucky (license number 3251P) and its NPI number is 1144478710. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (606) 874-1444.

Contact Information

	Allen Family Clinic Pllc.
	27 Ballpark St Allen KY 41601
	(606) 874-1444
	(606) 874-1446

Primary Care Clinic Profile

Full Name	Allen Family Clinic Pllc.
Speciality	Clinic/center - Primary Care
Location	27 Ballpark St, Allen, Kentucky
Authorized Official Name and Position	Trevor Jones (OWNER)
Authorized Official Contact	6068741444
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Allen Family Clinic Pllc. Po Box 262 Allen KY 41601-0262 Ph: (606) 874-1444	Allen Family Clinic Pllc. 27 Ballpark St Allen KY 41601 Ph: (606) 874-1444

NPI Details:

NPI Number	1144478710
Provider Enumeration Date	09/08/2008
Last Update Date	09/08/2008

Medical Identifiers

Medical identifiers for Allen Family Clinic Pllc. such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1144478710	NPI	-	NPPES
78013828	Medicaid	KY

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
261QP2300X	Clinic/center - Primary Care	3251P (Kentucky)	Primary

News Archive

Lack of physical activity and life expectancy: an interview with Dr I-Min Lee

With the approach of the Olympic Games, a group of researchers throughout the world thought that it would be a good time to draw the attention of the world to the health dangers of being physically inactive.

Amgen seeks EMA approval for marketing talimogene laherparepvec

Amgen today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) via the centralized procedure for talimogene laherparepvec seeking approval for the treatment of adults with melanoma that is regionally or distantly metastatic.

20% of adolescents smoke

As many as 20% of adolescents from 11 to 17 years of age smoke. This was the result of the nationwide German Health Interview and Examination Survey for Children and Adolescents (KiGGS), performed by the Robert Koch Institute and presented by the sociologist Thomas Lampert in the current edition of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2008; 105[15]: 265-71).

Additional data from Aegerion Pharmaceuticals' ongoing lomitapide Phase III trial

Aegerion Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of cardiovascular and metabolic disease, today announced additional data from its ongoing Phase III trial involving its lead cholesterol management compound, lomitapide (AEGR-733), which is a microsomal triglyceride transfer protein (MTP) inhibitor small molecule drug.

Allen Family Clinic Pllc. - Primary Care in Allen, KY